Improving Care for Anxiety in Pediatric Settings
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Anxiety Disorders
- Sponsor
- University of California, San Diego
- Locations
- 1
- Primary Endpoint
- Clinical Severity Rating on Anxiety Diagnostic Interview Schedule for Children for primary anxiety disorder
- Status
- Withdrawn
- Last Updated
- 6 years ago
Overview
Brief Summary
This study will compare the effectiveness of delivering cognitive behavioral therapy for children with anxiety disorders through in-person contact versus through workbooks and telephone communication.
Detailed Description
Approximately 13% of adolescents aged 9 to 17 suffer from an anxiety disorder, which can cause disruptive fear, worry, or uneasiness that impairs their normal functioning. These anxiety disorders can include generalized anxiety disorder (GAD), phobias, panic disorder, and obsessive-compulsive disorder (OCD), and they often co-occur with a second anxiety disorder or another mental or behavioral disorder, like depression. Research on interventions such as cognitive behavioral therapy (CBT) indicates that these interventions are helpful to children who suffer from anxiety disorders, but are not always used. This study will examine the feasibility of implementing CBT for children between the ages of 8 and 13 in two different forms: through in-person contact at the pediatric primary care setting and through telephone-based contact. Participants in this study will be randomly assigned to receive either cognitive behavioral therapy in primary care (CBT-PC) or therapist-assisted bibliotherapy in primary care (TAB-PC). In CBT-PC, participants will have therapy administered by a child anxiety specialist, and the parents of participants will learn how to support the new skills their children learn in therapy. In TAB-PC, parents will receive educational workbooks and ongoing support over the phone from a child anxiety specialist to learn how to use CBT skills to manage their children's fears and worries. Participation in this study will last 3 to 4 months, with therapy visits occuring once a week at the beginning and tapering to once every other week at the end of treatment. At pre-treatment, mid-treatment, post-treatment, and a 3-month follow-up, participants will undergo structured clinical interviews to assess their anxiety levels and the severity of their conditions.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Meets DSM-IV criteria for one of the following disorders: separation anxiety disorder, social phobia, generalized anxiety disorder, specific phobia, or obsessive-compulsive disorder
- •Takes a medication and has maintained a stable dose for 3 months before baseline assessment
- •Pediatric medical care is provided through one of the participating primary care clinics
- •Parent and child are fluent in English
Exclusion Criteria
- •Presence of a life threatening condition or a medical illness that would make participation unsafe
- •Diagnosed with bipolar disorder I, mental retardation, or autism or has psychotic symptoms
- •Acutely suicidal or homicidal or exhibiting dangerous behavior
- •Parents do not consent for diagnosis and progress to be shared with their child's primary care physician
Outcomes
Primary Outcomes
Clinical Severity Rating on Anxiety Diagnostic Interview Schedule for Children for primary anxiety disorder
Time Frame: Measured at pre-treatment and post-treatment
Secondary Outcomes
- Clinical Global Impression scale-Improvement Change(Measured at pre-treatment, mid-treatment, post-treatment, and a 3-month follow-up)
- Screening for Anxiety Related Emotional Disorders (SCARED) parent and child self-report scales(Measured at pre-treatment, mid-treatment, post-treatment, and a 3-month follow-up)